Search | OpenScholar

Search results

134 results found

Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson’s disease: a case series

Publication: Journal Article

Sethi, KD, RA Hauser, SH Isaacson, and T McClain. 2009. “Levodopa/Carbidopa/Entacapone 200/50/200 Mg (Stalevo 200) in the Treatment of Parkinson’s Disease: A Case Series”. J Cases.

Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1

Publication: Journal Article

Zesiewicz, TA, WR Shimberg, RA Hauser, W Robinson, MC Wilson, and KL Sullivan. 2008. “Chorea As a Side Effect of Gabapentin (Neurontin) in a Patient With Complex Regional Pain Syndrome Type 1”. Clin Rheumatol.

Caffeine and Progression of Parkinson Disease.

Publication: Journal Article

Simon, DK, CJ Swearingen, RA Hauser, JM Trugman, MJ Aminoff, C Singer, D Truong, and BC Tilley. 2008. “Caffeine and Progression of Parkinson Disease.”. Clin Neuropharmacol.

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.

Publication: Journal Article

Hauser, RA, LM Shulman, JM Trugman, JW Roberts, A Mori, R Ballerini, and NM Sussman. 2008. “Study of Istradefylline in Patients With Parkinson’s Disease on Levodopa With Motor Fluctuations.”. Mov Disord.

Medical treatment of motor and nonmotor features of Parkinson’s disease.

Publication: Journal Article

Zesiewicz, TA, and RA Hauser. 2007. “Medical Treatment of Motor and Nonmotor Features of Parkinson’s Disease.”. Continuum.

Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson’s disease.

Publication: Journal Article

Hauser, RA, L Salin, N Juhel, and VL Konyago. 2007. “Randomized Trial of the Triple Monoamine Reuptake Inhibitor NS 2330 (tesofensine) in Early Parkinson’s Disease.”. Movement Disorders.

Initial management of Parkinson’s disease in a Florida community. J Applied Research 2004;4:95-98.

Publication: Journal Article

Zesiewicz, TA, SN Carter, KL Sullivan, JS Staffetti, PB Dunne, and RA Hauser. 2004. “Initial Management of Parkinson’s Disease in a Florida Community. J Applied Research 2004;4:95-98.”. J Applied Research.

Substantial improvement in a Meige's syndrome patient with levetiracetam treatment. Movement Disorders 2004;19:1518-1521.

Publication: Journal Article

Zesiewicz, TA, ED Louis, KL Sullivan, M Menkin, PB Dunne, and RA Hauser. 2004. “Substantial Improvement in a Meige’s Syndrome Patient With Levetiracetam Treatment. Movement Disorders 2004;19:1518-1521.”. Movement Disorders.

Essential tremor. Epidemiology, diagnosis, and treatment. Neurologist 2004;10:250-258.

Publication: Journal Article

Sullivan, KL, RA Hauser, and TA Zesiewicz. 2004. “Essential Tremor. Epidemiology, Diagnosis, and Treatment. Neurologist 2004;10:250-258.”. Neurologist.

Double-blinded, placebo-controlled study of entacapone in levodopa-treated patients with Parkinson disease. Archives of neurology, 61(10), 1563.

Publication: Journal Article

Olanow, CW, K Kieburtz, M Stern, R Watts, JW Langston, M Guarnieri, RA Hauser, and J Hubble. 2004. “Double-Blinded, Placebo-Controlled Study of Entacapone in Levodopa-Treated Patients With Parkinson Disease. Archives of Neurology, 61(10), 1563.”. Archives of Neurology.